Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders

Depression: an inflammatory illness?: Figure 1

(2012) Rajeev Krishnadas et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Molecular Validation of the Acute Phencyclidine Rat Model for Schizophrenia: Identification of Translational Changes in Energy Metabolism and Neurotransmission

(2012) Agnes Ernst et al.   JOURNAL OF PROTEOME RESEARCH

Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice

(2012) Ajaykumar N Sharma et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Systematic Review and UK-Based Study ofPARK2 (parkin), PINK1, PARK7 (DJ-1)andLRRK2in early-onset Parkinson's disease

(2012) Laura L. Kilarski et al.   MOVEMENT DISORDERS

Identification of a biological signature for schizophrenia in serum

(2011) E Schwarz et al.   MOLECULAR PSYCHIATRY

Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency

(2011) P-S Cheah et al.   MOLECULAR PSYCHIATRY

Cognitive and Emotional Alterations Are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome

(2011) Anne-Laure Dinel et al.   PLoS One

Senescence of the Brain: Focus on Cognitive Kinases

(2010) S. Govoni et al.   CURRENT PHARMACEUTICAL DESIGN

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

(2010) P C Guest et al.   MOLECULAR PSYCHIATRY

A historical perspective on leptin

(2010) Douglas L Coleman   NATURE MEDICINE

Neurobehavioral deficits in db/db diabetic mice

(2010) Ajaykumar N. Sharma et al.   PHYSIOLOGY & BEHAVIOR

Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry

(2010) Divya Krishnamurthy et al.   PROTEOMICS

Common features between diabetes mellitus and Alzheimer’s disease

(2009) J. Götz et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH